SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001297399-04-000001
Filing Date
2004-07-19
Accepted
2004-07-19 14:36:47
Documents
1
Period of Report
2004-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2912
  Complete submission text file 0001297399-04-000001.txt   4595
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C?O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address 410-631-6325
Spengler William (Reporting) CIK: 0001297399 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23736 | Film No.: 04919896